
Plexus (PLXS) Stock Forecast & Price Target
Plexus (PLXS) Analyst Ratings
Bulls say
Plexus is viewed positively because its diversified exposure to regulated, high-complexity markets supports durable growth, with Industrial, Aerospace/Defense, and Healthcare all contributing to a stronger multi-year pipeline. Its FY27 and FY28 EPS estimates were raised to $10.26 and $12.16, respectively, as revenue momentum broadened, design wins hit record levels, and management expects more than $400 million of growth this year from new programs. Margin and cash generation also look set to improve as operating margin holds above 6%, capacity is added modularly, and free cash flow is expected to rebound in 2027 after near-term investment pressure.
Bears say
Plexus is facing a negative setup because its earnings visibility is vulnerable to global supply chain instability, elongated lead times, and persistent shortages in PCB, memory, and dual-use AI components, even if pricing inflation is largely passed through. The company also depends heavily on retaining its largest customers and sustaining demand across aerospace, healthcare, and industrial markets, while weakness in global electronics demand, tariff-related slowdown risks, and slower program ramps could reduce wins replenishment and funnel conversion. In addition, increased compensation, technology, and ramp investments may pressure operating margin below the 6% target, and any disruption in manufacturing facilities or weaker business mix could compound execution risk as the CFO transition adds near-term uncertainty.
This aggregate rating is based on analysts' research of Plexus and is not a guaranteed prediction by Public.com or investment advice.
Plexus (PLXS) Analyst Forecast & Price Prediction
Start investing in Plexus (PLXS)
Order type
Buy in
Order amount
Est. shares
0 shares